Changing partners at the dance

References

• Biron CA, Sen G. C. In: Knipe DMea, ed. Fields Virology, Fourth Edition: Lippincott, Williams, and Wilkins, 2001.
   Google Scholar
• Brierley MM, Fish EN. Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry. J Interferon Cytokine Res 2002; 22:835 - 45; http://dx.doi.org/10.1089/107999002760274845; PMID: 12396722
   PubMed Web of Science ®Google Scholar
• Cho SS, Bacon CM, Sudarshan C, Rees RC, Finbloom D, Pine R, et al. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J Immunol 1996; 157:4781 - 9; PMID: 8943379
   PubMed Web of Science ®Google Scholar
• Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC, Morinobu A, et al. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 2002; 297:2063 - 6; http://dx.doi.org/10.1126/science.1074900; PMID: 12242445
   PubMed Web of Science ®Google Scholar
• van Boxel-Dezaire AH, Rani MR, Stark GR. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 2006; 25:361 - 72; http://dx.doi.org/10.1016/j.immuni.2006.08.014; PMID: 16979568
   PubMed Web of Science ®Google Scholar
• Ho HH, Ivashkiv LB. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J Biol Chem 2006; 281:14111 - 8; http://dx.doi.org/10.1074/jbc.M511797200; PMID: 16571725
   PubMed Web of Science ®Google Scholar
• García-Sastre A, Biron CA. Type 1 interferons and the virus-host relationship: a lesson in détente. Science 2006; 312:879 - 82; http://dx.doi.org/10.1126/science.1125676; PMID: 16690858
   PubMed Web of Science ®Google Scholar
• Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol 2009; 9:480 - 90; http://dx.doi.org/10.1038/nri2580; PMID: 19543225
   PubMed Web of Science ®Google Scholar
• Darnell JE Jr., Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264:1415 - 21; http://dx.doi.org/10.1126/science.8197455; PMID: 8197455
   PubMed Web of Science ®Google Scholar
• Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4:69 - 77; http://dx.doi.org/10.1038/ni875; PMID: 12483210
   PubMed Web of Science ®Google Scholar
• Zhong Z, Wen Z, Darnell JE Jr.. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 264:95 - 8; http://dx.doi.org/10.1126/science.8140422; PMID: 8140422
   PubMed Web of Science ®Google Scholar
• Lai CF, Ripperger J, Morella KK, Jurlander J, Hawley TS, Carson WE, et al. Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements. J Biol Chem 1996; 271:13968 - 75; http://dx.doi.org/10.1074/jbc.271.24.13968; PMID: 8662928
   PubMed Web of Science ®Google Scholar
• Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE Jr., et al. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 1995; 181:1755 - 62; http://dx.doi.org/10.1084/jem.181.5.1755; PMID: 7722452
   PubMed Web of Science ®Google Scholar
• Caldenhoven E, Buitenhuis M, van Dijk TB, Raaijmakers JA, Lammers JW, Koenderman L, et al. Lineage-specific activation of STAT3 by interferon-gamma in human neutrophils. J Leukoc Biol 1999; 65:391 - 6; PMID: 10080544
   PubMed Web of Science ®Google Scholar
• Shuai K, Schindler C, Prezioso VR, Darnell JE Jr.. Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 1992; 258:1808 - 12; http://dx.doi.org/10.1126/science.1281555; PMID: 1281555
   PubMed Web of Science ®Google Scholar
• Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol 2004; 76:314 - 21; http://dx.doi.org/10.1189/jlb.0204117; PMID: 15123776
   PubMed Web of Science ®Google Scholar
• Finbloom DS, Winestock KD. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 1995; 155:1079 - 90; PMID: 7543512
   PubMed Web of Science ®Google Scholar
• Habib T, Nelson A, Kaushansky K. IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. J Allergy Clin Immunol 2003; 112:1033 - 45; http://dx.doi.org/10.1016/j.jaci.2003.08.039; PMID: 14657853
   PubMed Web of Science ®Google Scholar
• Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 1998; 95:15623 - 8; http://dx.doi.org/10.1073/pnas.95.26.15623; PMID: 9861020
   PubMed Web of Science ®Google Scholar
• Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011; 472:481 - 5; http://dx.doi.org/10.1038/nature09907; PMID: 21478870
   PubMed Web of Science ®Google Scholar
• Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell JE Jr.. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci U S A 1996; 93:7673 - 8; http://dx.doi.org/10.1073/pnas.93.15.7673; PMID: 8755534
   PubMed Web of Science ®Google Scholar
• Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, Williams BR, et al. Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J 2000; 19:263 - 72; http://dx.doi.org/10.1093/emboj/19.2.263; PMID: 10637230
   PubMed Web of Science ®Google Scholar
• Lee CK, Rao DT, Gertner R, Gimeno R, Frey AB, Levy DE. Distinct requirements for IFNs and STAT1 in NK cell function. J Immunol 2000; 165:3571 - 7; PMID: 11034357
   PubMed Web of Science ®Google Scholar
• Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002; 169:4279 - 87; PMID: 12370359
   PubMed Web of Science ®Google Scholar
• Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol 2000; 1:70 - 6; http://dx.doi.org/10.1038/76940; PMID: 10881178
   PubMed Web of Science ®Google Scholar
• Shuai K, Stark GR, Kerr IM, Darnell JE Jr.. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 1993; 261:1744 - 6; http://dx.doi.org/10.1126/science.7690989; PMID: 7690989
   PubMed Web of Science ®Google Scholar
• Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer zum Büschenfelde KH, Neurath MF. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J Immunol 1998; 160:3642 - 7; PMID: 9558063
   PubMed Web of Science ®Google Scholar
• Lawless VA, Zhang S, Ozes ON, Bruns HA, Oldham I, Hoey T, et al. Stat4 regulates multiple components of IFN-gamma-inducing signaling pathways. J Immunol 2000; 165:6803 - 8; PMID: 11120802
   PubMed Web of Science ®Google Scholar
• O’Sullivan A, Chang HC, Yu Q, Kaplan MH. STAT4 is required for interleukin-12-induced chromatin remodeling of the CD25 locus. J Biol Chem 2004; 279:7339 - 45; http://dx.doi.org/10.1074/jbc.M309979200; PMID: 14660657
   PubMed Web of Science ®Google Scholar
• Lee SH, Fragoso MF, Biron CA. Cutting edge: a novel mechanism bridging innate and adaptive immunity: IL-12 induction of CD25 to form high-affinity IL-2 receptors on NK cells. J Immunol 2012; 189:2712 - 6; http://dx.doi.org/10.4049/jimmunol.1201528; PMID: 22888135
   PubMed Web of Science ®Google Scholar
• Miyagi T, Gil MP, Wang X, Louten J, Chu WM, Biron CA. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J Exp Med 2007; 204:2383 - 96; http://dx.doi.org/10.1084/jem.20070401; PMID: 17846149
   PubMed Web of Science ®Google Scholar
• Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999; 10:105 - 15; http://dx.doi.org/10.1016/S1074-7613(00)80011-4; PMID: 10023775
   PubMed Web of Science ®Google Scholar
• Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, et al. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 2006; 12:11 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-04-1752; PMID: 16397018
   PubMed Web of Science ®Google Scholar
• Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, et al. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res 2006; 66:2544 - 52; http://dx.doi.org/10.1158/0008-5472.CAN-05-2203; PMID: 16510571
   PubMed Web of Science ®Google Scholar
• Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med 1999; 189:63 - 73; http://dx.doi.org/10.1084/jem.189.1.63; PMID: 9874564
   PubMed Web of Science ®Google Scholar
• Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996; 84:431 - 42; http://dx.doi.org/10.1016/S0092-8674(00)81288-X; PMID: 8608597
   PubMed Web of Science ®Google Scholar
• Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996; 84:443 - 50; http://dx.doi.org/10.1016/S0092-8674(00)81289-1; PMID: 8608598
   PubMed Web of Science ®Google Scholar
• Gil MP, Salomon R, Louten J, Biron CA. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 2006; 107:987 - 93; http://dx.doi.org/10.1182/blood-2005-07-2834; PMID: 16210337
   PubMed Web of Science ®Google Scholar
• Gil MP, Bohn E, O’Guin AK, Ramana CV, Levine B, Stark GR, et al. Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci U S A 2001; 98:6680 - 5; http://dx.doi.org/10.1073/pnas.111163898; PMID: 11390995
   PubMed Web of Science ®Google Scholar
• Costa-Pereira AP, Tininini S, Strobl B, Alonzi T, Schlaak JF, Is’harc H, et al. Mutational switch of an IL-6 response to an interferon-gamma-like response. Proc Natl Acad Sci U S A 2002; 99:8043 - 7; http://dx.doi.org/10.1073/pnas.122236099; PMID: 12060750
   PubMed Web of Science ®Google Scholar
• Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 2010; 28:445 - 89; http://dx.doi.org/10.1146/annurev-immunol-030409-101212; PMID: 20192806
   PubMed Web of Science ®Google Scholar
• Kanno Y, Vahedi G, Hirahara K, Singleton K, O’Shea JJ. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol 2012; 30:707 - 31; http://dx.doi.org/10.1146/annurev-immunol-020711-075058; PMID: 22224760
   PubMed Web of Science ®Google Scholar
• Biron CA, Nguyen KB, Pien GC. Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr Top Microbiol Immunol 2002; 263:7 - 27; http://dx.doi.org/10.1007/978-3-642-56055-2_2; PMID: 11987821
   PubMed Web of Science ®Google Scholar
• Mack EA, Kallal LE, Demers DA, Biron CA. Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection. MBio 2011; 2; http://dx.doi.org/10.1128/mBio.00169-11; PMID: 21828218
   PubMed Web of Science ®Google Scholar
• Pien GC, Nguyen KB, Malmgaard L, Satoskar AR, Biron CA. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J Immunol 2002; 169:5827 - 37; PMID: 12421964
   PubMed Web of Science ®Google Scholar
• Frucht DM, Aringer M, Galon J, Danning C, Brown M, Fan S, et al. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J Immunol 2000; 164:4659 - 64; PMID: 10779770
   PubMed Web of Science ®Google Scholar
• Longman RS, Braun D, Pellegrini S, Rice CM, Darnell RB, Albert ML. Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. Blood 2007; 109:1113 - 22; http://dx.doi.org/10.1182/blood-2006-05-023465; PMID: 17018853
   PubMed Web of Science ®Google Scholar
• van Boxel-Dezaire AH, Zula JA, Xu Y, Ransohoff RM, Jacobberger JW, Stark GR. Major differences in the responses of primary human leukocyte subsets to IFN-beta. J Immunol 2010; 185:5888 - 99; http://dx.doi.org/10.4049/jimmunol.0902314; PMID: 20956346
   PubMed Web of Science ®Google Scholar
• Qing Y, Stark GR. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem 2004; 279:41679 - 85; http://dx.doi.org/10.1074/jbc.M406413200; PMID: 15284232
   PubMed Web of Science ®Google Scholar
• Lehtonen A, Matikainen S, Julkunen I. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J Immunol 1997; 159:794 - 803; PMID: 9218597
   PubMed Web of Science ®Google Scholar
• Wong LH, Sim H, Chatterjee-Kishore M, Hatzinisiriou I, Devenish RJ, Stark G, et al. Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1. J Biol Chem 2002; 277:19408 - 17; http://dx.doi.org/10.1074/jbc.M111302200; PMID: 11909852
   PubMed Web of Science ®Google Scholar
• Baranek T, Manh TP, Alexandre Y, Maqbool MA, Cabeza JZ, Tomasello E, et al. Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. Cell Host Microbe 2012; 12:571 - 84; http://dx.doi.org/10.1016/j.chom.2012.09.002; PMID: 23084923
   PubMed Web of Science ®Google Scholar
• Orange JS, Biron CA. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 1996; 156:1138 - 42; PMID: 8557990
   PubMed Web of Science ®Google Scholar
• Gil MP, Ploquin MJ, Watford WT, Lee SH, Kim K, Wang X, et al. Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function. Blood 2012; 120:3718 - 28; http://dx.doi.org/10.1182/blood-2012-05-428672; PMID: 22968462
   PubMed Web of Science ®Google Scholar
• Bacon CM, Petricoin EF 3rd, Ortaldo JR, Rees RC, Larner AC, Johnston JA, et al. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci U S A 1995; 92:7307 - 11; http://dx.doi.org/10.1073/pnas.92.16.7307; PMID: 7638186
   PubMed Web of Science ®Google Scholar
• Watford WT, Hissong BD, Durant LR, Yamane H, Muul LM, Kanno Y, et al. Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii. J Exp Med 2008; 205:2803 - 12; http://dx.doi.org/10.1084/jem.20081461; PMID: 19001140
   PubMed Web of Science ®Google Scholar
• Wegenka UM, Buschmann J, Lütticken C, Heinrich PC, Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol 1993; 13:276 - 88; PMID: 7678052
   PubMed Web of Science ®Google Scholar
• Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994; 77:63 - 71; http://dx.doi.org/10.1016/0092-8674(94)90235-6; PMID: 7512451
   PubMed Web of Science ®Google Scholar
• Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, et al. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 1996; 5:449 - 60; http://dx.doi.org/10.1016/S1074-7613(00)80501-4; PMID: 8934572
   PubMed Web of Science ®Google Scholar
• Takeda K, Kaisho T, Yoshida N, Takeda J, Kishimoto T, Akira S. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol 1998; 161:4652 - 60; PMID: 9794394
   PubMed Web of Science ®Google Scholar
• Gimeno R, Lee CK, Schindler C, Levy DE. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes. Mol Cell Biol 2005; 25:5456 - 65; http://dx.doi.org/10.1128/MCB.25.13.5456-5465.2005; PMID: 15964802
   PubMed Web of Science ®Google Scholar
• Tanabe Y, Nishibori T, Su L, Arduini RM, Baker DP, David M. Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. J Immunol 2005; 174:609 - 13; PMID: 15634877
   PubMed Web of Science ®Google Scholar
• O’Farrell AM, Liu Y, Moore KW, Mui AL. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J 1998; 17:1006 - 18; http://dx.doi.org/10.1093/emboj/17.4.1006; PMID: 9463379
   PubMed Web of Science ®Google Scholar
• Riley JK, Takeda K, Akira S, Schreiber RD. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem 1999; 274:16513 - 21; http://dx.doi.org/10.1074/jbc.274.23.16513; PMID: 10347215
   PubMed Web of Science ®Google Scholar
• Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Förster I, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999; 10:39 - 49; http://dx.doi.org/10.1016/S1074-7613(00)80005-9; PMID: 10023769
   PubMed Web of Science ®Google Scholar
• Narimatsu M, Maeda H, Itoh S, Atsumi T, Ohtani T, Nishida K, et al. Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells. Mol Cell Biol 2001; 21:6615 - 25; http://dx.doi.org/10.1128/MCB.21.19.6615-6625.2001; PMID: 11533249
   PubMed Web of Science ®Google Scholar
• Yang J, Chatterjee-Kishore M, Staugaitis SM, Nguyen H, Schlessinger K, Levy DE, et al. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res 2005; 65:939 - 47; PMID: 15705894
   PubMed Web of Science ®Google Scholar
• Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 1997; 94:3801 - 4; http://dx.doi.org/10.1073/pnas.94.8.3801; PMID: 9108058
   PubMed Web of Science ®Google Scholar
• Alonzi T, Middleton G, Wyatt S, Buchman V, Betz UA, Müller W, et al. Role of STAT3 and PI 3-kinase/Akt in mediating the survival actions of cytokines on sensory neurons. Mol Cell Neurosci 2001; 18:270 - 82; http://dx.doi.org/10.1006/mcne.2001.1018; PMID: 11591128
   PubMed Web of Science ®Google Scholar
• Chapman RS, Lourenco PC, Tonner E, Flint DJ, Selbert S, Takeda K, et al. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 1999; 13:2604 - 16; http://dx.doi.org/10.1101/gad.13.19.2604; PMID: 10521404
   PubMed Web of Science ®Google Scholar
• Sartor CI, Dziubinski ML, Yu CL, Jove R, Ethier SP. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res 1997; 57:978 - 87; PMID: 9041204
   PubMed Web of Science ®Google Scholar
• Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, et al. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 1996; 88:809 - 16; PMID: 8704235
   PubMed Web of Science ®Google Scholar
• Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, et al. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A 1996; 93:9148 - 53; http://dx.doi.org/10.1073/pnas.93.17.9148; PMID: 8799169
   PubMed Web of Science ®Google Scholar
• Chiarle R, Simmons WJ, Cai H, Dhall G, Zamo A, Raz R, et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med 2005; 11:623 - 9; http://dx.doi.org/10.1038/nm1249; PMID: 15895073
   PubMed Web of Science ®Google Scholar
• Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, et al. Stat3 as an oncogene. Cell 1999; 98:295 - 303; http://dx.doi.org/10.1016/S0092-8674(00)81959-5; PMID: 10458605
   PubMed Web of Science ®Google Scholar
• Ruzek MC, Miller AH, Opal SM, Pearce BD, Biron CA. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J Exp Med 1997; 185:1185 - 92; http://dx.doi.org/10.1084/jem.185.7.1185; PMID: 9104805
   PubMed Web of Science ®Google Scholar
• Rogge L, D’Ambrosio D, Biffi M, Penna G, Minetti LJ, Presky DH, et al. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol 1998; 161:6567 - 74; PMID: 9862683
   PubMed Web of Science ®Google Scholar
• Miyagi T, Takehara T, Nishio K, Shimizu S, Kohga K, Li W, et al. Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection. J Hepatol 2010; 53:424 - 30; http://dx.doi.org/10.1016/j.jhep.2010.03.018; PMID: 20554341
   PubMed Web of Science ®Google Scholar
• Edlich B, Ahlenstiel G, Zabaleta Azpiroz A, Stoltzfus J, Noureddin M, Serti E, et al. Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients. Hepatology 2012; 55:39 - 48; http://dx.doi.org/10.1002/hep.24628; PMID: 21898483
   PubMed Web of Science ®Google Scholar
• Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 2012; 36:166 - 74; http://dx.doi.org/10.1016/j.immuni.2012.01.011; PMID: 22365663
   PubMed Web of Science ®Google Scholar
• Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005; 202:637 - 50; http://dx.doi.org/10.1084/jem.20050821; PMID: 16129706
   PubMed Web of Science ®Google Scholar
• Cui W, Liu Y, Weinstein JS, Craft J, Kaech SM. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 2011; 35:792 - 805; http://dx.doi.org/10.1016/j.immuni.2011.09.017; PMID: 22118527
   PubMed Web of Science ®Google Scholar
• Chapgier A, Boisson-Dupuis S, Jouanguy E, Vogt G, Feinberg J, Prochnicka-Chalufour A, et al. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet 2006; 2:e131; http://dx.doi.org/10.1371/journal.pgen.0020131; PMID: 16934001
   PubMed Web of Science ®Google Scholar
• Chapgier A, Wynn RF, Jouanguy E, Filipe-Santos O, Zhang S, Feinberg J, et al. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol 2006; 176:5078 - 83; PMID: 16585605
   PubMed Web of Science ®Google Scholar
• Dupuis S, Dargemont C, Fieschi C, Thomassin N, Rosenzweig S, Harris J, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001; 293:300 - 3; http://dx.doi.org/10.1126/science.1061154; PMID: 11452125
   PubMed Web of Science ®Google Scholar
• Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, Al-Jumaah S, et al. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 2003; 33:388 - 91; http://dx.doi.org/10.1038/ng1097; PMID: 12590259
   PubMed Web of Science ®Google Scholar
• Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011; 208:1635 - 48; http://dx.doi.org/10.1084/jem.20110958; PMID: 21727188
   PubMed Web of Science ®Google Scholar
• Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357:1608 - 19; http://dx.doi.org/10.1056/NEJMoa073687; PMID: 17881745
   PubMed Web of Science ®Google Scholar
• Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007; 448:1058 - 62; http://dx.doi.org/10.1038/nature06096; PMID: 17676033
   PubMed Web of Science ®Google Scholar
• de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008; 205:1543 - 50; http://dx.doi.org/10.1084/jem.20080321; PMID: 18591412
   PubMed Web of Science ®Google Scholar
• Casanova JL, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity 2012; 36:515 - 28; http://dx.doi.org/10.1016/j.immuni.2012.03.016; PMID: 22520845
   PubMed Web of Science ®Google Scholar
• Siegel AM, Heimall J, Freeman AF, Hsu AP, Brittain E, Brenchley JM, et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 2011; 35:806 - 18; http://dx.doi.org/10.1016/j.immuni.2011.09.016; PMID: 22118528
   PubMed Web of Science ®Google Scholar